IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.
复制标题
DOI:
10.1016/j.jaci.2009.03.041
复制
发表时间:
2009-06
影响因子:
14.2
通讯作者:
Guttman-Yassky, Emma
中科院分区:
文献类型:
--
作者:
Nograles, Kristine E.;Zaba, Lisa C.;Shemer, Avner;Fuentes-Duculan, Judilyn;Cardinale, Irma;Kikuchi, Toyoko;Ramon, Michal;Bergman, Reuven;Krueger, James G.;Guttman-Yassky, Emma
Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases. Up-regulated Th17/IL-23 pathway was demonstrated in psoriasis. Although potential involvement of Th17 T-cells in AD was suggested during acute disease, the role of these cells in chronic AD remains unclear. To examine differences in IL-23/Th17 signal between these diseases and establish relative frequencies of T-cell subsets in AD. Skin biopsies and peripheral blood were collected from chronic AD (n=12) and psoriasis (n=13) patients. Relative frequencies of CD4+ and CD8+ T-cell subsets within these two compartments were examined by intracellular cytokine staining and flow cytometry. In peripheral blood, no significant difference was found in percentages of different T-cell subsets between these diseases. In contrast, psoriatic skin had significantly increased frequencies of Th1 and Th17 T-cells compared with AD, while Th2 T-cells were significantly elevated in AD. Distinct IL-22 producing CD4+ and CD8+ T-cell populations were significantly increased in AD skin, compared to psoriasis. IL-22+CD8+ T-cell frequency correlated with AD disease severity. Our data established that T-cells could independently express IL-22 even with low expression levels of IL-17. This argues for a functional specialization of T-cells such that “T17” and “T22” T-cells may drive different features of epidermal pathology in inflammatory skin diseases, including induction of AMPs for “T17” T-cells and epidermal hyperplasia for “T22” T-cells. Given the clinical correlation with disease severity, further characterization of “T22” T-cells is warranted, and may have future therapeutic implications.
登录
查看更多内容
DOI:
10.4049/jimmunol.181.7.4733
发表时间:
2008-10-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kryczek I;Bruce AT;Gudjonsson JE;Johnston A;Aphale A;Vatan L;Szeliga W;Wang Y;Liu Y;Welling TH;Elder JT;Zou W
通讯作者:
Zou W
影响因子:
8.6
作者:
Kim, Byung Eui;Leung, Donald Y. M.;Howell, Michael D.
通讯作者:
Howell, Michael D.
影响因子:
2.5
作者:
Oflazoglu, Ezogelin;Simpson, Eric L.;Gerber, Hans-Peter
通讯作者:
Gerber, Hans-Peter
影响因子:
4.6
作者:
Boniface, K.;Guignouard, E.;Morel, F.
通讯作者:
Morel, F.
影响因子:
64.8
作者:
Zheng, Yan;Danilenko, Dimitry M.;Ouyang, Wenjun
通讯作者:
Ouyang, Wenjun